Background. Micronutrients are associated with dementia and cognitive decline among older adults. However, nutritional biomarkers of such decline have not been identified. We attempted to identify nutritional biomarkers that were independent risk markers of cognitive decline in a population of older Japanese.
T HE World Health Organization (1) reported that nearly 35 .6 million people live with dementia worldwide. This number is expected to double by 2030 and more than triple by 2050. The current worldwide cost of treating and caring for people with dementia is more than US$604 billion per year, which includes the cost of providing health and social care as well the reduced and lost incomes of people with dementia and their caregivers. Dementia is clearly a growing public health concern.
Long-term pathological changes cause gradual deterioration in cognitive function among people with dementia, including those with Alzheimer's disease (AD). Because of the irreversibility of dementia, measures for effective prevention during the long asymptomatic latent period are desirable. Cognitive decline (CD) is the prodromal stage of AD and the trajectories of decline may differ among subtype of AD (2) . CD is strongly associated with onset of mild cognitive impairment and AD. Wilson and colleagues (3) reported that, as compared with a group of people with no cognitive impairment, the annual rate of CD was more than double in a group with mild cognitive impairment and more than quadruple in a group with AD. Prevention of CD might assist in controlling onset of future dementia.
Studies have reported several risk factors for incident CD, including social demographic factors (4) (5) (6) , diseases (7) (8) (9) (10) , genes (11) (12) (13) (14) (15) (16) (17) , physical function (18) (19) (20) (21) (22) (23) (24) (25) , and social activity (26) . Moreover, nutritional factors, and especially micronutrients (27) (28) (29) (30) , were recently found to be associated with dementia and CD. Nutritional biomarkers are used to measure nutritional status and are less subject to error, as compared with dietary data, in epidemiological studies as well as smaller clinical studies. However, despite the promise of nutritional biomarkers, only a few studies have investigated their association with Downloaded from https://academic.oup.com/biomedgerontology/article-abstract/69/10/1276/668319 by guest on 16 July 2018 cognitive function: low albumin (ALB) (31) and high mean corpuscular volume (MCV) (32) were significantly associated with CD in older adults, and low high-density lipoprotein cholesterol (HDL-C) (33) was a risk factor for memory decline in midlife. Although studies have reported associations between some nutritional biomarkers and CD, many nutritional biomarkers have not been examined. Furthermore, it is not known whether nutritional biomarkers are associated with CD after adjustment for sociomedical factors.
Identifying nutritional biomarkers of CD risk might yield new insights regarding physiological mechanisms in the prodromal stage of dementia. Moreover, an approach that uses a blood panel might be effective for use at the clinical stage. In this prospective study of community-living older adults, we measured a number of blood biomarkers and health-related factors at baseline. The Mini-Mental State Examination (MMSE) was then used to monitor the cognitive function of participants. The study had two objectives: to identify nutritional biomarkers of CD risk among a sample of older Japanese and to examine whether biomarkers identified as potential risk factors remained independently associated with CD after adjustment for potential confounders.
Methods
We launched longitudinal studies in co-operation with local governments in Kusatsu town, Gunma Prefecture (total population, n = 7,587; residents aged 70 years or older, n = 1,260) and Yoita town, Niigata Prefecture (total population, n = 7,370; residents aged 70 years or older, n = 1,385), Japan in 2001 and 2004. In addition to an annual preventive health check-up for citizens aged 40 years or older, older participants underwent an additional comprehensive geriatric assessment. The details of the study design have been previously reported (20) . All participants provided written informed consent under conditions approved by the Ethics Committee at Tokyo Metropolitan Institute of Gerontology.
The data source for the present study was 512 participants aged 70 years or older who lived in Kusatsu in 2002 and 637 participants aged 70 years or older who lived in Yoita in 2004 (a total of 1,149 participants at baseline). The participants were followed every year until 2006 in Kusatsu and until 2007 in Yoita (duration of follow-up, 1-4 years). The annual surveys and assessments were conducted in the same manner each year. To be eligible for the study, individuals had to complete baseline assessments (n = 1,025), be operationally defined as cognitively normal at baseline (MMSE score ≥24; n = 873), and be reevaluated using the MMSE at least once during the follow-up period (n = 682). The reasons for attrition during follow-up (from n = 873 to n = 682) included death (n = 25), need for care under the long-term care insurance program (n = 29), relocation (n = 7), and other, unknown reasons (n = 130). Ultimately, data from 682 of the 1,149 adults were included in the analysis, as shown in Figure 1 .
Blood Biomarkers
Blood testing included red blood cell (RBC) count, hematocrit (HT), MCV, hemoglobin (Hb), total cholesterol (TC), HDL-C, HbA1c, creatinine (Cr), ALB, blood glucose (BG), γ-glutamyl transpeptidase (γ-GTP), triglyceride (TG), and white blood cell (WBC) count (Kusatsu only). Nonfasting blood samples were collected using standard procedures. Samples in Kusatsu were analyzed at the Sanaikai Clinic, and samples in Yoita were analyzed at the Niigata Association of Occupational Health, Inc. Both laboratories are regularly monitored by several domestic authorities. The precision and accuracy of the lipid measurements at both laboratories have been certified by the Osaka Medical Center for Health Science and Promotion, in accordance with the requirements of the Centers for Disease Control-National Heart, Lung, and Blood Institute Lipid Standardization Program.
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Cognitive Function
Cognitive function was assessed with the MMSE, which was administered by well-trained personnel. The MMSE comprises 11 questions, and the score ranges from 0 to 30, with lower scores indicating poorer global cognitive ability. We defined CD as a decrease of at least 3 points on the MMSE during the follow-up period (20, 34) .
Other Measurements
The covariates included sex, age, educational attainment, years of education, study area, living arrangement, frequency of going outdoors, alcohol drinking and smoking status, history of chronic diseases, body height and weight, body mass index, resting blood pressure, grip strength, usual gait speed, self-rated health, Tokyo Metropolitan Institute of Gerontology Index of Competence, and Geriatric Depression scale, short version. Well-trained personnel interviewed the participants.
Chronic diseases included clinically relevant medical conditions (hypertension, hyperlipidemia, stroke, heart disease, diabetes mellitus, gout, cancer, liver disease, and anemia). For each condition, participants were asked whether a physician had diagnosed the specific condition (yes or no). A summary variable (0-9) was created to represent comorbidity.
Grip strength (kg) was measured in the dominant hand using a standard hydraulic handgrip dynamometer: participants were requested to squeeze the handle as hard as they could. Gait speed was measured over a straight 11-m walkway marked with tape at 3 and 8 m (35) . Participants were requested to walk at their usual pace. Well-trained staff measured the time required to walk 5 m and calculated usual gait speed (expressed as m/s). Usual gait performance was measured once. Grip strength was measured twice, and the better of the two results was recorded.
Statistical Analyses
The Mann-Whitney U test and χ 2 test were used to compare sociomedical characteristics at baseline between individuals who developed CD during follow-up and those who did not. Associations of measures of nutritional biomarkers at baseline with CD were tested using multiple logistic regression models. To examine independent associations between measures of nutritional biomarkers at baseline with subsequent CD, we adjusted for confounding factors by using multiple logistic regression models in which each measurement of a blood biomarker was defined as an independent variable and subsequent CD was defined as a dependent variable. Two models were used. In the first, the covariates were sex, age, and years of education (Model 1). The second model included the covariates in Model 1 plus all factors that were significantly associated with CD in univariate analysis. In addition, body mass index and follow-up year were added as important covariates (Model 2). The statistical models were run separately. Statistics were computed using SPSS (version 18.0; SPSS, Inc., Chicago, IL), and the level of significance was set at p < .05.
Results
Among study participants at baseline, average age (standard deviation) was 75.5 (4.4) years and 59.7% of participants were women, 59.2% were from the Yoita survey, 54.0% were never drinkers, and 62.6% were never smokers. The average number of years of education was 8.5 (2.2), average number of chronic diseases was 1.2 (1.0), mean score on the Tokyo Metropolitan Institute of Gerontology Index of Competence was 12.0 (1.3), mean score on the Geriatric Depression scale short version was 3.9 (2.4), and mean score on the MMSE was 27.3 (1.9). At baseline, all biomarkers showed no correlation with MMSE scores. As compared with participants excluded from the analysis (reasons for exclusion: incomplete baseline data, n = 124; cognitive deterioration at baseline, n = 152; dropout, n = 191), participants who were followed-up (n = 682) had higher HT, Hb, TC, HDL-C, ALB, and MMSE scores, and lower HbA1c, Cr, and BG at baseline.
During a median follow-up of 2.7 years, 115 (16.9%) of 682 adults developed CD. Table 1 shows the baseline demographic and health characteristics of individuals who did and did not develop CD during the follow-up period. At baseline, adults who developed CD were more likely to be older, live in Kusatsu, live alone, and have a low usual gait speed, and less likely to have hyperlipidemia and a high MMSE score, all of which were included as potential confounders in multivariate analysis. Among blood biomarkers, adults who developed CD had a lower RBC, higher MCV, lower TC, lower HDL-C, and lower ALB.
The associations of the abovementioned five blood biomarkers with subsequent CD are shown in were 1.73 (1.06-2.83) and 1.15 (0.68-1.92) for HDL-C and 2.20 (1.33-3.66) and 1.13 (0.65-1.97) for ALB. Table 3 shows the independent associations of RBC, HDL-C, and ALB with CD, after controlling for potential confounders. Among men and women combined, all three nutritional biomarkers remained significantly associated with CD in the fully adjusted model. Among the lowest and middle tertiles of RBC, the ORs for CD were 2.62 (1.44-4.74) and 2.18 (1.20-3.96), respectively, as compared with participants of the same sex in the highest tertile. The corresponding ORs were 1.81 (1.05-3.22) and 1.03 (0.58-1.83) for HDL-C, and 2.06 (1.14-3.77) and 1.02 (0.54-1.94) for ALB, respectively. In particular, women had higher ORs for subsequent CD. The corresponding ORs were 3.27 (1.44-7.43) and 2.37 (1.02-5.51) for RBC, 2.07 (1.05-4.50) and 1.04 (0.47-2.32) for HDL-C, and 2.63 (1.20-5.45) and 0.91 (0.43-1.89) for ALB, respectively, in Model 2. Furthermore, RBC, HDL-C, and ALB were analyzed simultaneously in the same model as independent variables. All three nutritional biomarkers remained independently significant in Model 1 for men and women combined (data not shown). 
Discussion
Recent studies (27) (28) (29) (30) suggest that micronutrients such as vitamins and fatty acids are associated with cognitive function; however, only a few studies have studied associations between blood biomarkers and CD. Ng and colleagues (31) found that low ALB was associated with increased risk of CD among older Asians. The present prospective study of community-dwelling older Japanese confirmed those earlier results. Moreover, the present study is the first to show that the blood biomarkers RBC and HDL-C-in addition to ALB-were independent predictors of CD after adjusting for potential confounders.
Evidence suggests that there are three mechanisms by which RBC, HDL-C, and ALB may predict CD development. First, nutritional mechanisms may mediate the association. Iron deficiency due to nutritional deficiency leads to production of smaller, paler RBCs. Persons with low energy intake, especially those with limited intake of saturated fat, tend to have low HDL-C values. Nutritional intake positively correlates with ALB level in blood. Our findings suggest that low nutritional status is a common feature in the prodromal stage of CD. Like all organs, the brain needs nutrients to build and maintain its tissues (30) . Lack of a specific nutrient due to low nutritional status might have a negative effect on cognitive function. Second, frailty may contribute to CD. Low nutritional status has been identified as a frailty phenotype. Low ALB is a potential marker of frailty (36) , and HDL-C level helps in assessing the prognosis of patients at risk of frailty syndrome (37) . A longitudinal association between frailty and incident CD was reported among community-dwelling older adults (38), suggesting that frailty has an important role in the association between these biomarkers and CD. Third, certain diseases might have mediating roles in the pathophysiology of CD. Low RBC and HDL-C values are linked to RBC disorders, atherosclerotic disease, and dyslipidemia (19, 39, 40) . In addition, chronic systemic inflammatory activity due to age-associated disease inversely correlates with ALB values (31) . Although we examined histories of anemia, artery disease, metabolic disease, and considered these associations with CD in our statistical analysis, other chronic diseases might contribute to CD.
In univariate analysis, MCV was marginally associated with CD. However, multiple logistic regression (fully adjusted model) showed a significant association: among the lowest and middle tertiles of MCV, the ORs (95% confidence interval) for CD were 0.51 (0.29-0.90) and 0.84 (0.50-1.43), as compared with participants of the same sex in the highest tertile (data not shown in table). MCV is calculated by dividing HT by RBC count and represents RBC volume. Large RBCs are more fragile and have greater difficulty changing shape to fit through capillaries. Although we did not observe a clear association between MCV and CD, an earlier study reported an association among older Americans (32) . We conclude that MCV is an intriguing potential risk factor for CD among elderly Japanese.
We compared sociomedical characteristics with CD, age, study area, living arrangement, history of hyperlipidemia, usual gait speed, and MMSE score at baseline. Studies have shown an association between gait speed and CD (20, (22) (23) (24) (25) . An association between higher MMSE scores and CD was attributed to a ceiling effect in a previous study (20) . Our findings support previous results on gait and cognitive function. Study area and living arrangement were associated with CD; however, further study is necessary to identify sociological factors that affect cognitive function.
This study has several strengths. First, we measured a large number of blood biomarkers, which enabled us to examine multiple risks simultaneously. RBC, HDL-C, and ALB were independently associated with CD after adjusting for sex, age, and years of education. Each of these biomarkers may have a protective effect against brain damage, via acid-base balance (41) , vasoprotection (42) , and antioxidant activity (43) . Identification of the independent importance of RBC, HDL-C, and ALB warrants further study. Second, we assessed a number of sociomedical factors and included them in the statistical models, which revealed that RBC, HDL-C, and ALB were significantly associated with CD even after adjusting for sociodemographic factors, disease status, physical performance, and social activities.
Several limitations of this study should be noted. First, our covariates did not include all factors reported as risk markers of CD in epidemiological studies. For example, there has been growing interest in micronutrients such as vitamins B, C, D, and E, ω-3 fatty acid, trans fats, docosahexaenoic acid, and eicosapentaenoic acid (27) (28) (29) (30) . Moreover, studies of some types of inflammation and some genes have reported associations with CD (11) (12) (13) (14) (15) (16) (17) 30, 31) . Further investigation is necessary to explore associations of nutritional biomarkers with cognitive function, while controlling for micronutrients, inflammation, and genes. A second limitation was that the participants were healthier than the general elderly population. A comparison of those excluded from the analysis (n = 467) and those followedup (n = 682) showed that the latter had higher HT, Hb, TC, HDL-C, ALB, and MMSE scores, and lower HbA1c, Cr, and BG at baseline. These findings indicate that the excluded group had worse nutritional and cognitive status. This limitation may have attenuated the association between nutritional biomarkers and CD in our sample. Third, the significance of the associations of nutritional biomarkers with CD substantially differed between men and women. Fewer men than women were enrolled, which raises the possibility of type 2 error in the analysis of men. Additional studies are needed, to increase the robustness of the data. Finally, we assessed cognition using only the MMSE and defined cognitive decline as a decrease of three or more points on the MMSE during the 4-year follow-up period. Although the MMSE is a convenient measure of global cognition and has been widely used in previous studies, it is not the only instrument for such assessment. In addition, alternative definitions of CD, such as a decrease of two or more points, have often been used. The present definition may have increased the specificity but decreased the sensitivity of screening for CD. Other measures of cognitive function were not available in the present study, and further research is thus needed, to explore the associations of nutritional biomarkers with these other measures of cognitive function.
In conclusion, this prospective study revealed inverse associations between three nutritional biomarkers and cognitive decline in a general population of older Japanese, even after adjusting for potential confounders. Our findings indicate that low RBC, HDL-C, and ALB were risk markers of subsequent CD. Although causality cannot be established, each of these nutritional biomarkers is feasible for cost-effective early clinical screening and assists in practical dietary intervention for cognitive outcome in particular.
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